Trametinib is primarily used to treat melanoma, particularly in cases where the cancer has metastasized or cannot be surgically removed. It is especially effective against melanoma that has mutations in the BRAF gene. Additionally, trametinib is often used in combination with other drugs like dabrafenib to enhance its efficacy. Besides melanoma, trametinib is also being investigated for its effectiveness against other cancers, such as non-small cell lung cancer (NSCLC) and thyroid cancer.
